179
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Coenzyme Q10 phospholipidic vesicular formulations for treatment of androgenic alopecia: ex vivo permeation and clinical appraisal

, , & ORCID Icon
Pages 1513-1522 | Received 16 Mar 2021, Accepted 26 May 2021, Published online: 07 Jun 2021

References

  • Davis DS, Callender VD. Review of quality of life studies in women with alopecia. Int J Womens Dermatol. 2018;4:18–22.
  • Dey-Rao R, Sinha AA. A genomic approach to susceptibility and pathogenesis leads to identifying potential novel therapeutic targets in androgenetic alopecia. Genomics. 2017;109(3–4):165–176.
  • Vogt A, Pfannes EK, Fimmel S, et al. Infundibular protein and RNA microarray analyses from affected and clinically non‐affected scalp in male androgenetic alopecia patients. Exp Dermatol. 2017;26(6):518–521.
  • Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med. 2002;4(22):1–11.
  • Kaufman KD. Androgens and alopecia. Mol Cell Endocrinol. 2002;198(1–2):89–95.
  • Rushton DH, Ramsay ID, Norris MJ, et al. Natural progression of male pattern baldness in young men. Clin Exp Dermatol. 1991;16(3):188–192.
  • Alves R. Androgenetic alopecia: a review and emerging treatments. Clin Res Dermatol Open Access. 2017;4:1–13.
  • Ramot Y, Czarnowicki T, Zlotogorski A. Finasteride induced gynecomastia: case report and review of the literature. Int J Trichology. 2009;1(1):27–29.
  • Dawber RPR, Rundegren J. Hypertrichosis in females applying minoxidil topical solution and in normal controls. J Eur Acad Dermatol Venereol. 2003;17(3):271–275.
  • Prie BE, Iosif L, Tivig I, et al. Oxidative stress in androgenetic alopecia. J Med Life. 2016;9(1):79–83.
  • Trueb RM. Oxidative stress in ageing of hair. Int J Trichology. 2009;1(1):6–14.
  • Erdogan HK, Bulur I, Kocaturk E, et al. The role of oxidative stress in early-onset androgenetic alopecia. J Cosmet Dermatol. 2017;16(4):527–530.
  • Hatem S, Nasr M, Moftah NH, et al. Clinical cosmeceutical repurposing of melatonin in androgenic alopecia using nanostructured lipid carriers prepared with antioxidant oils. Expert Opin Drug Deliv. 2019;15(10):927–935.
  • Hatem S, Nasr M, Moftah NH, et al. Melatonin vitamin C-based nanovesicles for treatment of androgenic alopecia: design, characterization and clinical appraisal. Eur J Pharm Sci. 2018;122:246–253.
  • Bentinger M, Brismar K, Dallner G. The antioxidant role of coenzyme Q. Mitochondrion. 2007;7:S41–S50.
  • Cicero FG, Colletti A. Nutraceuticals and dietary supplements to improve quality of life and outcomes in heart failure patients. Curr Pharm Design. 2017;23(8):1265–1272.
  • Lance J, McCabe S, Clancy RL, et al. Coenzyme Q10- a therapeutic agent. Medsurg Nurs. 2012;21(6):367.
  • Turunen M, Olsson J, Dallner G. Metabolism and function of coenzyme Q. Biochim Biophys Acta Biomembr. 2004;1660:171–199.
  • Zhai J, Bo Y, Lu Y, et al. Effects of coenzyme Q10 on markers of inflammation: a systematic review and meta-analysis. PloS One. 2017;12(1):e0170172.
  • Giesen M, Welß T, Zur Wiesche ES, et al. Coenzyme Q10 has anti-aging effects on human hair. Int J Cosmet Sci. 2009;31(2): 154–155.
  • Sguizzato M, Mariani P, Spinozzi F, et al. Ethosomes for coenzyme Q10 cutaneous administration: from design to 3D skin tissue evaluation. Antioxidants. 2020;9(6):485.
  • Gokce EH, Korkmaz E, Tuncay-Tanriverdi S, et al. A comparative evaluation of coenzyme Q10-loaded liposomes and solid lipid nanoparticles as dermal antioxidant carriers. Int J Nanomedicine. 2012;7:5109–5117.
  • Tessema EN, Bosse K, Wohlrab J, et al. Investigation of ex vivo skin penetration of coenzyme Q10 from microemulsions and hydrophilic cream. Skin Pharmacol Physiol. 2020;33(6):293–299.
  • Onoue S, Uchida A, Kuriyama K, et al. Novel solid self-emulsifying drug delivery system of conenzyme Q10 with improved photochemical and pharmacokinetic behaviors. Eur J Pharm Sci. 2012;46(5):492–499.
  • Ashique S, Sandhu NK, Haque SN, et al. A systemic review on topical marketed formulations, natural products and oral supplements to prevent androgenic alopecia: a review. Nat Prod Bioprospect. 2020;10(6): 345–365.
  • Lee SW, Juhasz M, Mobasher P, et al. A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women. J Drugs Dermatol. 2018;17(4):457–463.
  • Nasr M, Al-Karaki R. Nanotechnological innovations enhancing the topical therapeutic efficacy of quercetin: a succinct review. Curr Drug Deliv. 2020;17(4):270–278.
  • Bseiso EA, Nasr M, Sammour O, et al. Recent advances in topical formulation carriers of antifungal agents. Indian J Dermatol Venereol Leprol. 2015;81(5):457–463.
  • Hatem S, Nasr M, Elkheshen SA, et al. Recent advances in antioxidant cosmeceutical topical delivery. Curr Drug Deliv. 2018;15(7):953–964.
  • Bsieso EA, Nasr M, Moftah NH, et al. Could nanovesicles containing a penetration enhancer clinically improve the therapeutic outcome in skin fungal diseases? Nanomedicine (London. England). 2015;10:2017–2031.
  • El-Kayal M, Nasr M, Elkheshen S, et al. Colloidal (-)-epigallocatechin-3-gallate vesicular systems for prevention and treatment of skin cancer: a comprehensive experimental study with preclinical investigation. Eur J Pharm Sci. 2019;137:104972.
  • Shaaban M, Nasr M, Tawfik AA, et al. Novel bergamot oil nanospanlastics combined with PUVB therapy as a clinically translatable approach for vitiligo treatment. Drug Deliv Trans Res. 2019;9(6):1106–1116.
  • Aldalaen S, Nasr M, El-Gogary RI. Angiogenesis and collagen promoting nutraceutical-loaded nanovesicles for wound healing. J Drug Deliv Sci Technol. 2020;56:101548.
  • Abd-Allah H, Abdel-Aziz RTA, Nasr M. Chitosan nanoparticles making their way to clinical practice: a feasibility study on their topical use for acne treatment. Int J Biol Macromol. 2020;156:262–270.
  • Shaaban M, Nasr M, Tawfik AA, et al. Bergamot oil as an integral component of nanostructured lipid carriers and a photosensitizer for photodynamic treatment of vitiligo: Characterization and clinical experimentation. Expert Opin Drug Deliv. 2021;18(1):139–150.
  • Fadel M, Kassab K, Samy N, et al. Nanovesicular photodynamic clinical treatment of resistant plantar warts. Curr Drug Deliv. 2020;17(5):396–405.
  • Amer SS, Nasr M, Mamdouh W, et al. Insights on the use of nanocarriers for acne alleviation. Curr Drug Deliv. 2019;16(1):18–25.
  • Amer SS, Nasr M, Abdel-Aziz RTA, et al. Cosm-nutraceutical nanovesicles for acne treatment: Physicochemical characterization and exploratory clinical experimentation. Int J Pharm. 2020;577:119092.
  • Nasr M, Abdel-Hamid S, Moftah NH, et al. Jojoba Oil Soft Colloidal Nanocarrier of a Synthetic Retinoid: Preparation. Characterization and Clinical Efficacy in Psoriatic Patients.Curr Drug Deliv 2017;14:426–432.
  • Roque LV, Dias IS, Cruz N, et al. Design of finasteride-loaded nanoparticles for potential treatment of alopecia. Skin Pharmacol Physiol. 2017;30(4):197–204.
  • Santos AC, Miguel P-S, Guerra C, et al. Topical minoxidil-loaded nanotechnology strategies for alopecia. Cosmetics. 2020;7(2):21.
  • Zeb A, Arif ST, Malik M, et al. Potential of nanoparticulate carriers for improved drug delivery via skin. J Pharm Investig. 2019;49(5):485–517.
  • Hua S. Lipid-based nano-delivery systems for skin delivery of drugs and bioactives. Front Pharmacol. 2015;6:219.
  • Fadel M, Samy N, Nasr M, et al. Topical colloidal indocyanine green-mediated photodynamic therapy for treatment of basal cell carcinoma. Pharm Dev Technol. 2017;22(4):545–550.
  • Nasr M, Mansour S, Mortada ND, et al. Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul. 2008;25(7):499–512.
  • El Zaafarany GM, Awad GA, Holayel SM, et al. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm. 2010;397(1–2):164–172.
  • Abdelgawad R, Nasr M, Moftah NH, et al. Phospholipid membrane tubulation using ceramide doping “Cerosomes”: Characterization and clinical application in psoriasis treatment. Eur J Pharm Sci. 2017;101:258–268.
  • Abdul-Rasheed OF, Farid YY. Development of a new high perfomance liquid chromatography method for measurement of coenzyme Q10 in healthy blood plasma. Saudi Med J. 2009;30(9):1138–1143.
  • Takeuchi H, Mano Y, Terasaka S, et al. Usefulness of rat skin as a substitute for human skin in the in vitro skin permation study. Exp Anim. 2011;60(4):373–384.
  • Neupane R, Boddu SHS, Renukuntla J, et al. Alternatives to biological skin in permeation studies: current trends and possibilities. Pharmaceutics. 2020;12:152.
  • Shelke NB, Sairam M, Halligudi SB, et al. Development of transdermal drug-delivery films with castor-oil-based polyurethanes. J Appl Polym Sci. 2007;103(2):779–788.
  • Shelke NB, Aminabhavi TM. Synthesis and characterization of methoxypolyethyleneglycol and lauric acid grafted novel polyurethanes for controlled release of nifedipine. J Appl Polym Sci. 2007;105(4):2155–2163.
  • Nasr M, Abdel-Hamid S. Optimizing the dermal accumulation of a tazarotene microemulsion using skin deposition modeling. Drug Dev Ind Pharm. 2016;42(4):636–643.
  • Lee W-C, Tsai T-H. Preparation and characterization of liposomal conezyme Q10 for in vivo topical application. Int J Pharm. 2010;395(1–2):78–83.
  • Squizzato M, Mariani P, Spinozzi F, et al. Ethosomes for coenzyme Q10 cutaneous administration: From design to 3D skin tissue evaluation. Antioxidants. 2020;9(6):485.
  • Shelke S, Shahi S, Jadhav K, et al. Thermoreversible nanoethosomal gel for the intranasal delivery of Eletriptan hydrobromide. J Mater Sci Mater Med. 2016;27(6):103.
  • Bseiso EA, Nasr M, Sammour OA, et al. Novel nail penetration enhancer containing vesicles “nPEVs” for treatment of onychomycosis. Drug Deliv. 2016;23(8):2813–2819.
  • Nasr M, Wahdan SA. Neuroprotective effects of novel nanosystems simultaneously loaded with vinpocetine and piracetam after intranasal administration. Life Sci. 2019;226:117–129.
  • Ashraf O, Nasr M, Nebsen M, et al. In vitro stabilization ad in vivo improvement of ocular pharmacokinetics of the multi-therapeutic agent baicalin: delineating the most suitable vesicular systems. Int J Pharm. 2018;539(1–2):83–94.
  • Pinsolle A, Roy P, Cansell M. Modulation of enzymatic PS synthesis by liposome membrane composition. Colloids Surf B Biointerfaces. 2014;115:157–163.
  • Petelska AD, Figaszewski ZA. Effect of pH on the interfacial tension of bilayer lipid membrane formed from phosphatidylcholine or phosphatidylserine. Biochim Biophys Acta. 2002;1561(2):135–146.
  • Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs liposomes. Biomaterials. 2000;21(18):1879–1885.
  • Abdulbaqi IM, Darwis Y, Khan NAK, et al. Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal propertues, in vivo studies, and clinical trials. Int J Nanomedicine. 2016;11:2279–2304.
  • Honary S, Zahir F. Effect of Zeta potential on the properties of nano-drug delivery systems – a review (Part 2). Trop J Pharm Res. 2013;12:265.
  • Sa W, Kayserb O, Rh M. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev. 2004;56(9):1257–1272.
  • Jacobs C, Kayser O, Muller RH. Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. Int J Pharm. 2000;196(2):161–164.
  • Li H, Chen F. Preparation and quality evaluation of coenzyme Q10 long-circulating liposomes. Saudi J Biol Sci. 2017;24(4):797–802.
  • Richard C, Cassel S, Blanzat M. Vesicular systems for dermal and transdermal drug delivery. RSC Adv. 2021;11(1):442–451.
  • Pierre MBR, Costa IDM. Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Arch Dermatol Res. 2011;303(9):607.
  • Gomes MJ, Martins S, Ferreira D, et al. Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies. Int J Nanomedicine. 2014;9:1231–1242.
  • Wang W, Chen L, Huang X, et al. Preparation and characterization of minoxidil loaded nanostructured lipid carriers. AAPS PharmSciTech. 2017;18(2):509–516.
  • Noor NM, Sheikh K, Somavarapu S, et al. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery. Eur J Pharm Biopharm. 2017;117:372–384.
  • Kumar R, Singh B, Bakshi G, et al. Development of liposomal systems of finasteride for topical applications: design, characterization, and in vitro evaluation. Pharm Dev Technol. 2007;12(6):591–601.
  • Artmann C, Roding J, Ghyczy M, et al. Liposomes from soya phospholipids as percutaneous drug carriers. Arzneim Forsch. 1990;40:1365–1368.
  • Junginger HE, Hofland HE, Bouwstra JA. Liposomes and niosomes: interactions with human skin. Cosmetics Toiletries. 1991;106:45.
  • Lieb L, Ramachandran C, Egbaria K, et al. Topical delivery enhancement with multilamellar liposomes into pilosebaceous units. In vitro evaluation using fluorescent techniques with hamster ear model. J Invest Dermat. 1992;99(1):108–113.
  • Bernard E, Bubois JL, Wepeirre J. Importance of sebaceous glands in cutaneous penetration of an antiandrogen: target effect of liposomes. J Pharm Sci. 1997;86:573–578.
  • El-Menshawe SF, Sayed OM, Abou-Taleb HA, et al. Skin permeation enhancement of nicotinamide through using fluidization and deformability of positively charged ethosomal vesicles: a new approach for treatment of atopic eczema. J Drug Deliv Sci Technol. 2019;52:687–701.
  • Opatha SAT, Titapiwatanakun V, Chutoprapat R. Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics. 2020;12(9):855.
  • Tokudome Y, Saito Y, Sato F, et al. Preparation and characterization of ceramide-based liposomes with high fusion activity and high membrane fluidity. Colloids Surf B Biointerfaces. 2009;73(1):92–96.
  • Corbe E, Laugel C, Yagoubi N, et al. Role of ceramide structure and its microenvironment on the conformational order of model stratum corneum lipids mixtures: an approach by FTIR spectroscopy. Chem Phys Lipids. 2007;146(2):67–75.
  • Ascenso A, Raposo S, Batista C, et al. Development, characterization and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes and transethosomes. Int J Nanomedicine. 2015;10:5837–5851.
  • Garg V, Singh H, Bhatia A, et al. Systematic development of transethosomal gel system of piroxicam: formulation optimization, in vitro evaluation, and ex vivo assessment. AAPS PharmSciTech. 2017;18(1):58–71.
  • de Leeuw J, De Vijlder HC, Bjerring P, et al. Liposomes in dermatology today. J Eur Acad Dermatol Venereaol. 2009;23(5): 505–516.
  • Song CK, Balakrishnan P, Shim C-K, et al. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces. 2012;92:299–304.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.